CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer
Conditions
- Acinar Cell Adenocarcinoma of the Pancreas
- Duct Cell Adenocarcinoma of the Pancreas
- Recurrent Pancreatic Cancer
- Stage IV Pancreatic Cancer
Interventions
- DRUG: 6,8-bis(benzylthio)octanoic acid
- DRUG: oxaliplatin
- DRUG: leucovorin calcium
- DRUG: irinotecan hydrochloride
- DRUG: fluorouracil
- OTHER: laboratory biomarker analysis
Sponsor
Wake Forest University Health Sciences
Collaborators